MiRNA-31 encoded by the MIR31HG gene, positioned adjacent to CDKN2A/B at Chromosome 9, is compromised in >72% of GBM, and its reintroduction reduces tumor burden by inhibiting NF-κB signaling, independent of CDKN2A/B status [34]. Here, CDKN2A is linked to glioblastoma.